Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cis-atracurium versus atracurium for postoperative delirium after elective colorectal surgery
IRCT20250902067095N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2025
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative delirium (POD) and post-operative cognitive decline (POCD) comparing cisatracurium with atracurium (2 arms). Primary endpoints: Postoperative delirium and Postoperative cognitive dysfunction. Started Sep 2025; status: completed.
02
Drugs
cisatracuriumatracurium
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on IRCT20250902067095N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250902067095N1.